Search
Rislenemdaz
go.drugbank.com/drugs/DB12063InvestigationalMk 0657 has been used in trials studying the treatment of Major Depressive Disorder.
Categories: Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors, Heterocyclic Compounds, 1-RingOrteronel
go.drugbank.com/drugs/DB12066InvestigationalOrteronel has been investigated for the treatment of Prostate Cancer.
Categories: Heterocyclic Compounds, 1-RingSovaprevir
go.drugbank.com/drugs/DB12069InvestigationalSovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
Censavudine
go.drugbank.com/drugs/DB12074InvestigationalCensavudine has been used in trials studying the treatment of HIV-1 Infection.
Categories: Heterocyclic Compounds, 1-RingSurotomycin
go.drugbank.com/drugs/DB12076InvestigationalSurotomycin has a fourfold greater in vitro potency than vancomycin against C. … Surotomycin is non-inferior to vancomycin and offers a promising alternative for the treatment and prevention of C. diff infection.
Urelumab
go.drugbank.com/drugs/DB12077InvestigationalUrelumab is a fully human antibody that targets CD137. … Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma.
Naftopidil
go.drugbank.com/drugs/DB12092InvestigationalNaftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingMannitol busulfan
go.drugbank.com/drugs/DB12097ApprovedWithdrawnMm has been used in trials studying the treatment of Cocaine Dependence and Diabetes Mellitus, Type 2.
UK-396,082
go.drugbank.com/drugs/DB12099InvestigationalUK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.
Categories: Heterocyclic Compounds, 1-RingVaborbactam
go.drugbank.com/drugs/DB12107ApprovedInvestigationalVaborbactam is a β-lactamase inhibitor based on a cyclic boronic acid pharmacophore. … In August 2017, a combination antibacterial therapy under the market name Vabomere was approved by the FDA for the treatment of adult patients with complicated urinary tract infections (cUTI).